Zimmer Biomet Holdings, Inc. Reports First Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St set for higher open but weekly losses loom
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Zimmer Biomet (ZBH) PT Raised to $134 at Needham & Company
April 28, 2016 1:46 PM EDTNeedham & Company analyst Mike Matson reiterated a Buy rating and boosted his price target on Zimmer Biomet (NYSE: ZBH) to $134.00 (from $129.00).
Matson commented, "ZBH beat consensus revenue and EPS in 1Q16 and management raised guidance. Pro forma constant currency revenue growth improved to... More
